欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0508/003
药品名称Eligard 45 mg
活性成分
    • Leuprorelin acetate 45.0 mg
剂型Powder and solvent for solution for injection
上市许可持有人Recordati Industria Chimica E Farmaceutica S.p.A. In Breve Recordati S.p.A. Via Matteo Civitali 1 Milan
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
      Eligard 45 mg
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
      Eligard Depot 45 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Eligard
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Eligard
    • Latvia (LV)
      Eligard 45 mg pulveris un šķīdinātājs injekciju šķīduma pagatavošanai
    • Lithuania (LT)
      Eligard 45 mg milteliai ir tirpiklis injekciniam tirpalui
    • Estonia (EE)
      ELIGARD
    • Hungary (HU)
      Eligard 45 mg por és oldószer oldatos injekcióhoz
    • Bulgaria (BG)
      Eligard
    • Cyprus (CY)
      ELIGARD 45 MG POWDER + SOLVENT FOR SOL FOR INJ
    • Czechia (CZ)
      Eligard 45 mg
    • Romania (RO)
      Eligard 45 mg
    • Slovakia (SK)
      Eligard 45 mg
    • Slovenia (SI)
许可日期2007/08/28
最近更新日期2025/08/14
药物ATC编码
    • L02AE02 leuprorelin
申请类型
  • TypeLevel1：Line Extension
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase